Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A pill bottle and scattered pills on a pharmacy shelf in low light.

Jul 25, 2026

Reputation House Published Sector-Wide Analysis of Digital Reputation Across Leading U.S. Pharma Companies

A recent analysis by Reputation House reveals that digital reputational risks for leading U.S. pharmaceutical companies are deeply rooted in structural issues rather than isolated incidents. The study evaluated 17 major firms, focusing on how their digital presence is influenced by historical legal challenges and regulatory actions, particularly as AI-generated content increasingly shapes public perception.Using its AI-powered platform, Risk Check, Reputation House assessed the digital reputatio
A minimalist illustration of a heart and stethoscope in a dark palette.

Jul 25, 2026

Caristo Diagnostics Expands Executive Team, Naming David Vort Chief Commercial Officer and Chris Louk Chief Financial Officer

Caristo Diagnostics has announced the appointment of David Vort as Chief Commercial Officer and Chris Louk as Chief Financial Officer, aiming to enhance the global adoption of its AI-driven cardiovascular technologies.These strategic appointments come as Caristo seeks to expand its leadership team to better facilitate the growth of its innovative cardiovascular solutions. CEO Steve Deitsch emphasized the significance of these hires, noting Vort's extensive experience in building commercial organ
A blood sample on a microscope slide in a clinical lab setting.

Jul 25, 2026

Point of Care Diagnostics Market to Achieve US$ 88.3 Billion Market Value by 2034

The global Point of Care Diagnostics Market is projected to reach approximately US$ 88.3 billion by 2034, growing from US$ 49.8 billion in 2024, at a CAGR of 5.9% during the forecast period.This market expansion is driven by an increasing demand for rapid and accessible diagnostic solutions, allowing healthcare providers to deliver immediate results at or near the patient's location. This shift is crucial for enhancing clinical decision-making and reducing reliance on centralized laboratories. T
Obicetrapib capsule on a lab bench

Jul 25, 2026

NewAmsterdam Pharma gets positive CHMP opinion for obicetrapib-based Ubeslo and Evlarco, EC decision due 2H26

NewAmsterdam Pharma has received a favorable opinion from the CHMP regarding its products Ubeslo and Evlarco, paving the way for potential EU marketing authorization.The Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation for NewAmsterdam Pharma's Ubeslo and Evlarco, which are based on obicetrapib. This decision is significant as it sets the stage for an official decision from the European Commission, expected in the second half of 2026.Menarini, a key play
Silhouette of interlocking gears representing healthcare collaboration

Jul 25, 2026

BRICS Countries Unite To Build Resilient Digital Healthcare Systems

BRICS nations are joining forces to enhance their healthcare systems through the development of interoperable digital infrastructure and responsible AI, aiming to tackle shared challenges and promote patient-centric care.The collaboration among BRICS countries focuses on creating resilient healthcare systems that leverage digital technologies. Key challenges include limited interoperability, a rising burden of chronic diseases, workforce shortages, and the need for robust data governance. The BR
A stethoscope on a wooden desk next to an open patient health record in a dimly lit clinic.

Jul 25, 2026

BRICS Puts Digital Health and Responsible AI at Centre of Care

BRICS health leaders are advocating for enhanced digital health systems that ensure continuous patient care, addressing challenges such as chronic illnesses and unequal access to services.This discussion occurred during a side event at the 16th BRICS Health Ministers' Meeting, organized by India's National Health Authority. Experts emphasized the importance of interoperable health records and responsible AI in bridging gaps in patient care across various healthcare settings. Union Health Secreta
A minimalist illustration of a test tube and microscope in a dark color scheme.

Jul 25, 2026

What We're Watching at ADLM 2026: AI, Precision Diagnostics and Laboratory Innovation

As ADLM 2026 approaches, the spotlight is on advancements in AI, precision diagnostics, and laboratory automation. The Association for Diagnostics and Laboratory Medicine (ADLM) event in Anaheim, California, is set to gather thousands of professionals from the laboratory medicine field. This year's conference aims to explore the practical applications of artificial intelligence in laboratory settings, moving beyond theoretical discussions to focus on real-world implementations. Key questions in
A heart symbol with digital circuits

Jul 25, 2026

BRICS Nations Strengthen Health Cooperation Through Digital Innovation

At the recent 16th BRICS Health Ministers' meeting, Union Health Secretary Punya Salila Srivastava highlighted the integral role of digital health and AI in fostering universal health coverage among member nations.The BRICS nations are increasingly focusing on health cooperation as a foundational element of their partnership, emphasizing mutual learning and shared innovation. Srivastava pointed out that ensuring continuity of care is a significant challenge, necessitating interconnected healthca
A hand holding a syringe in a clinical workspace

Jul 25, 2026

BRICS Countries Unite To Build Resilient Digital Healthcare Systems

BRICS nations are joining forces to enhance their healthcare systems through the development of interoperable digital health infrastructures and responsible AI, focusing on overcoming shared challenges and fostering innovative, patient-centered care.The collaboration among BRICS countries aims to create robust healthcare systems that prioritize patient needs while addressing issues such as limited interoperability, chronic diseases, workforce shortages, and data governance. A significant resourc
A minimalist illustration of a robotic arm and a large language model in flat design.

Jul 25, 2026

The FDA was all in on AI. Will that change?

The FDA's commitment to artificial intelligence (AI) faces uncertainty following key leadership changes, particularly with the departure of Dr. Marty Makary, a strong advocate for a centralized AI strategy. Under his guidance, the FDA initiated the implementation of a large language model named Elsa, aimed at enhancing efficiency in reviews and evaluations by automating support tasks.Despite a significant increase in reported AI use cases—up 148% between 2024 and 2025—the future direction of AI
A medical chart and stethoscope in a consultation room at dusk.

Jul 25, 2026

BRICS Puts Digital Health and Responsible AI at Centre of Care

The recent BRICS Health Ministers’ Meeting emphasized the importance of integrating digital health systems and responsible AI to enhance patient care and address healthcare disparities among member nations.During a side event organized by India's National Health Authority, health leaders and policymakers discussed the need for interoperable health records to bridge gaps in patient care across various healthcare settings. Union Health Secretary Punya Salila Srivastava highlighted that continuity
A minimalist representation of a base editor and DNA strand in a dark color scheme.

Jul 25, 2026

AlphaFold AI redesigns gene-editing proteins to enhance safety, and biotech investors should pay attention

A new AI framework named ContactSeek, built on the advancements of AlphaFold3, is set to revolutionize gene-editing technologies by enhancing their safety and precision. This innovation is particularly significant for biotech investors and stakeholders in the field of gene therapy.ContactSeek addresses a critical challenge in gene editing: the risk of unintended DNA cuts. By utilizing AlphaFold3's structural predictions, the framework allows researchers to redesign base editors—molecular tools t